keyword
https://read.qxmd.com/read/38633805/evaluating-large-language-models-for-drafting-emergency-department-discharge-summaries
#1
Christopher Y K Williams, Jaskaran Bains, Tianyu Tang, Kishan Patel, Alexa N Lucas, Fiona Chen, Brenda Y Miao, Atul J Butte, Aaron E Kornblith
IMPORTANCE: Large language models (LLMs) possess a range of capabilities which may be applied to the clinical domain, including text summarization. As ambient artificial intelligence scribes and other LLM-based tools begin to be deployed within healthcare settings, rigorous evaluations of the accuracy of these technologies are urgently needed. OBJECTIVE: To investigate the performance of GPT-4 and GPT-3.5-turbo in generating Emergency Department (ED) discharge summaries and evaluate the prevalence and type of errors across each section of the discharge summary...
April 4, 2024: medRxiv
https://read.qxmd.com/read/38625909/learning-epistatic-polygenic-phenotypes-with-boolean-interactions
#2
JOURNAL ARTICLE
Merle Behr, Karl Kumbier, Aldo Cordova-Palomera, Matthew Aguirre, Omer Ronen, Chengzhong Ye, Euan Ashley, Atul J Butte, Rima Arnaout, Ben Brown, James Priest, Bin Yu
Detecting epistatic drivers of human phenotypes is a considerable challenge. Traditional approaches use regression to sequentially test multiplicative interaction terms involving pairs of genetic variants. For higher-order interactions and genome-wide large-scale data, this strategy is computationally intractable. Moreover, multiplicative terms used in regression modeling may not capture the form of biological interactions. Building on the Predictability, Computability, Stability (PCS) framework, we introduce the epiTree pipeline to extract higher-order interactions from genomic data using tree-based models...
2024: PloS One
https://read.qxmd.com/read/38570554/evaluating-large-language-models-as-agents-in-the-clinic
#3
JOURNAL ARTICLE
Nikita Mehandru, Brenda Y Miao, Eduardo Rodriguez Almaraz, Madhumita Sushil, Atul J Butte, Ahmed Alaa
No abstract text is available yet for this article.
April 3, 2024: NPJ Digital Medicine
https://read.qxmd.com/read/38533919/accurate-robust-and-scalable-machine-abstraction-of-mayo-endoscopic-subscores-from-colonoscopy-reports
#4
JOURNAL ARTICLE
Anna L Silverman, Balu Bhasuran, Arman Mosenia, Fatema Yasini, Gokul Ramasamy, Imon Banerjee, Saransh Gupta, Taline Mardirossian, Rohan Narain, Justin Sewell, Atul J Butte, Vivek A Rudrapatna
BACKGROUND: The Mayo endoscopic subscore (MES) is an important quantitative measure of disease activity in ulcerative colitis. Colonoscopy reports in routine clinical care usually characterize ulcerative colitis disease activity using free text description, limiting their utility for clinical research and quality improvement. We sought to develop algorithms to classify colonoscopy reports according to their MES. METHODS: We annotated 500 colonoscopy reports from 2 health systems...
March 26, 2024: Inflammatory Bowel Diseases
https://read.qxmd.com/read/38482890/real-world-effectiveness-of-ustekinumab-and-vedolizumab-in-tnf-exposed-pediatric-patients-with-ulcerative-colitis
#5
JOURNAL ARTICLE
Perseus V Patel, Amy Zhang, Balu Bhasuran, Vignesh G Ravindranath, Melvin B Heyman, Sofia G Verstraete, Atul J Butte, Michael J Rosen, Vivek A Rudrapatna
OBJECTIVES: Vedolizumab (VDZ) and ustekinumab (UST) are second-line treatments in pediatric patients with ulcerative colitis (UC) refractory to antitumor necrosis factor (anti-TNF) therapy. Pediatric studies comparing the effectiveness of these medications are lacking. Using a registry from ImproveCareNow (ICN), a global research network in pediatric inflammatory bowel disease, we compared the effectiveness of UST and VDZ in anti-TNF refractory UC. METHODS: We performed a propensity-score weighted regression analysis to compare corticosteroid-free clinical remission (CFCR) at 6 months from starting second-line therapy...
March 14, 2024: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/38459719/algorithmic-identification-of-treatment-emergent-adverse-events-from-clinical-notes-using-large-language-models-a-pilot-study-in-inflammatory-bowel-disease
#6
JOURNAL ARTICLE
Anna L Silverman, Madhumita Sushil, Balu Bhasuran, Dana Ludwig, James Buchanan, Rebecca Racz, Mahalakshmi Parakala, Samer El-Kamary, Ohenewaa Ahima, Artur Belov, Lauren Choi, Monisha Billings, Yan Li, Nadia Habal, Qi Liu, Jawahar Tiwari, Atul J Butte, Vivek A Rudrapatna
Outpatient clinical notes are a rich source of information regarding drug safety. However, data in these notes are currently underutilized for pharmacovigilance due to methodological limitations in text mining. Large language models (LLMs) like Bidirectional Encoder Representations from Transformers (BERT) have shown progress in a range of natural language processing tasks but have not yet been evaluated on adverse event (AE) detection. We adapted a new clinical LLM, University of California - San Francisco (UCSF)-BERT, to identify serious AEs (SAEs) occurring after treatment with a non-steroid immunosuppressant for inflammatory bowel disease (IBD)...
March 8, 2024: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38405831/a-comparative-study-of-zero-shot-inference-with-large-language-models-and-supervised-modeling-in-breast-cancer-pathology-classification
#7
Madhumita Sushil, Travis Zack, Divneet Mandair, Zhiwei Zheng, Ahmed Wali, Yan-Ning Yu, Yuwei Quan, Atul Butte
Although supervised machine learning is popular for information extraction from clinical notes, creating large, annotated datasets requires extensive domain expertise and is time-consuming. Meanwhile, large language models (LLMs) have demonstrated promising transfer learning capability. In this study, we explored whether recent LLMs can reduce the need for large-scale data annotations. We curated a manually labeled dataset of 769 breast cancer pathology reports, labeled with 13 categories, to compare zero-shot classification capability of the GPT-4 model and the GPT-3...
February 6, 2024: Research Square
https://read.qxmd.com/read/38395542/characterisation-of-digital-therapeutic-clinical-trials-a-systematic-review-with-natural-language-processing
#8
REVIEW
Brenda Y Miao, Madhumita Sushil, Ava Xu, Michelle Wang, Douglas Arneson, Ellen Berkley, Meera Subash, Rohit Vashisht, Vivek Rudrapatna, Atul J Butte
Digital therapeutics (DTx) are a somewhat novel class of US Food and Drug Administration-regulated software that help patients prevent, manage, or treat disease. Here, we use natural language processing to characterise registered DTx clinical trials and provide insights into the clinical development landscape for these novel therapeutics. We identified 449 DTx clinical trials, initiated or expected to be initiated between 2010 and 2030, from ClinicalTrials.gov using 27 search terms, and available data were analysed, including trial durations, locations, MeSH categories, enrolment, and sponsor types...
March 2024: The Lancet. Digital health
https://read.qxmd.com/read/38388841/to-do-no-harm-and-the-most-good-with-ai-in-health-care
#9
JOURNAL ARTICLE
Carey Beth Goldberg, Laura Adams, David Blumenthal, Patricia Flatley Brennan, Noah Brown, Atul J Butte, Morgan Cheatham, Dave deBronkart, Jennifer Dixon, Jeffrey Drazen, Barbara J Evans, Sara M Hoffman, Chris Holmes, Peter Lee, Arjun Kumar Manrai, Gilbert S Omenn, Jonathan B Perlin, Rachel Ramoni, Guillermo Sapiro, Rupa Sarkar, Harpreet Sood, Effy Vayena, Isaac S Kohane
No abstract text is available yet for this article.
March 2024: Nature Medicine
https://read.qxmd.com/read/38345264/predictive-modeling-of-drug-related-adverse-events-with-real-world-data-a-case-study-of-linezolid-hematologic-outcomes
#10
JOURNAL ARTICLE
Anu Patel, Sarah B Doernberg, Travis Zack, Atul J Butte, Kendra K Radtke
Electronic health records (EHRs) provide meaningful knowledge of drug-related adverse events (AEs) that are not captured in standard drug development and postmarketing surveillance. Using variables obtained from EHR data in the University of California San Francisco de-identified Clinical Data Warehouse, we aimed to evaluate the potential of machine learning to predict two hematological AEs, thrombocytopenia and anemia, in a cohort of patients treated with linezolid for 3 or more days. Features for model input were extracted at linezolid initiation (index), and outcomes were characterized from index to 14 days post-treatment...
February 12, 2024: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38241075/the-reporting-quality-of-machine-learning-studies-on-pediatric-diabetes-mellitus-systematic-review
#11
REVIEW
Zsombor Zrubka, Gábor Kertész, László Gulácsi, János Czere, Áron Hölgyesi, Hossein Motahari Nezhad, Amir Mosavi, Levente Kovács, Atul J Butte, Márta Péntek
BACKGROUND: Diabetes mellitus (DM) is a major health concern among children with the widespread adoption of advanced technologies. However, concerns are growing about the transparency, replicability, biasedness, and overall validity of artificial intelligence studies in medicine. OBJECTIVE: We aimed to systematically review the reporting quality of machine learning (ML) studies of pediatric DM using the Minimum Information About Clinical Artificial Intelligence Modelling (MI-CLAIM) checklist, a general reporting guideline for medical artificial intelligence studies...
January 19, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38223407/topic-modeling-on-clinical-social-work-notes-for-exploring-social-determinants-of-health-factors
#12
JOURNAL ARTICLE
Shenghuan Sun, Travis Zack, Christopher Y K Williams, Madhumita Sushil, Atul J Butte
OBJECTIVE: Existing research on social determinants of health (SDoH) predominantly focuses on physician notes and structured data within electronic medical records. This study posits that social work notes are an untapped, potentially rich source for SDoH information. We hypothesize that clinical notes recorded by social workers, whose role is to ameliorate social and economic factors, might provide a complementary information source of data on SDoH compared to physician notes, which primarily concentrate on medical diagnoses and treatments...
April 2024: JAMIA Open
https://read.qxmd.com/read/38219811/cross-institution-natural-language-processing-for-reliable-clinical-association-studies-a-methodological-exploration
#13
JOURNAL ARTICLE
Madhumita Sushil, Atul J Butte, Ewoud Schuit, Maarten van Smeden, Artuur M Leeuwenberg
OBJECTIVE: Natural language processing (NLP) of clinical notes in electronic medical records is increasingly used to extract otherwise sparsely available patient characteristics, to assess their association with relevant health outcomes. Manual data curation is resource intensive and NLP methods make these studies more feasible. However, the methodology of using NLP methods reliably in clinical research is understudied. The objective of this study is to investigate how NLP models could be used to extract study variables (specifically: exposures) to reliably conduct exposure-outcome association studies...
January 12, 2024: Journal of Clinical Epidemiology
https://read.qxmd.com/read/38123252/assessing-the-potential-of-gpt-4-to-perpetuate-racial-and-gender-biases-in-health-care-a-model-evaluation-study
#14
JOURNAL ARTICLE
Travis Zack, Eric Lehman, Mirac Suzgun, Jorge A Rodriguez, Leo Anthony Celi, Judy Gichoya, Dan Jurafsky, Peter Szolovits, David W Bates, Raja-Elie E Abdulnour, Atul J Butte, Emily Alsentzer
BACKGROUND: Large language models (LLMs) such as GPT-4 hold great promise as transformative tools in health care, ranging from automating administrative tasks to augmenting clinical decision making. However, these models also pose a danger of perpetuating biases and delivering incorrect medical diagnoses, which can have a direct, harmful impact on medical care. We aimed to assess whether GPT-4 encodes racial and gender biases that impact its use in health care. METHODS: Using the Azure OpenAI application interface, this model evaluation study tested whether GPT-4 encodes racial and gender biases and examined the impact of such biases on four potential applications of LLMs in the clinical domain-namely, medical education, diagnostic reasoning, clinical plan generation, and subjective patient assessment...
January 2024: The Lancet. Digital health
https://read.qxmd.com/read/38045390/epistasis-regulates-genetic-control-of-cardiac-hypertrophy
#15
Qianru Wang, Tiffany Tang, Nathan Youlton, Chad Weldy, Ana Kenney, Omer Ronen, John Hughes, Elizabeth Chin, Shirley Sutton, Abhineet Agarwal, Xiao Li, Merle Behr, Karl Kumbier, Christine Moravec, W H Wilson Tang, Kenneth Margulies, Thomas Cappola, Atul Butte, Rima Arnaout, James Brown, James Priest, Victoria Parikh, Bin Yu, Euan Ashley
The combinatorial effect of genetic variants is often assumed to be additive. Although genetic variation can clearly interact non-additively, methods to uncover epistatic relationships remain in their infancy. We develop low-signal signed iterative random forests to elucidate the complex genetic architecture of cardiac hypertrophy. We derive deep learning-based estimates of left ventricular mass from the cardiac MRI scans of 29,661 individuals enrolled in the UK Biobank. We report epistatic genetic variation including variants close to CCDC141 , IGF1R , TTN , and TNKS ...
November 20, 2023: Research Square
https://read.qxmd.com/read/37987017/epistasis-regulates-genetic-control-of-cardiac-hypertrophy
#16
Qianru Wang, Tiffany M Tang, Nathan Youlton, Chad S Weldy, Ana M Kenney, Omer Ronen, J Weston Hughes, Elizabeth T Chin, Shirley C Sutton, Abhineet Agarwal, Xiao Li, Merle Behr, Karl Kumbier, Christine S Moravec, W H Wilson Tang, Kenneth B Margulies, Thomas P Cappola, Atul J Butte, Rima Arnaout, James B Brown, James R Priest, Victoria N Parikh, Bin Yu, Euan A Ashley
The combinatorial effect of genetic variants is often assumed to be additive. Although genetic variation can clearly interact non-additively, methods to uncover epistatic relationships remain in their infancy. We develop low-signal signed iterative random forests to elucidate the complex genetic architecture of cardiac hypertrophy. We derive deep learning-based estimates of left ventricular mass from the cardiac MRI scans of 29,661 individuals enrolled in the UK Biobank. We report epistatic genetic variation including variants close to CCDC141 , IGF1R , TTN , and TNKS...
November 8, 2023: medRxiv
https://read.qxmd.com/read/37986977/personalizing-treatment-selection-in-crohn-s-disease-a-meta-analysis-of-individual-participant-data-from-fifteen-randomized-controlled-trials
#17
Vivek A Rudrapatna, Vignesh G Ravindranath, Douglas V Arneson, Arman Mosenia, Atul J Butte, Shan Wang
BACKGROUND: Meta-analyses have found anti-TNF drugs to be the best treatment, on average, for Crohn's disease. We performed a subgroup analysis to determine if it is possible to achieve more efficacious outcomes by individualizing treatment selection. METHODS: We obtained participant-level data from 15 trials of FDA-approved treatments (N=5703). We used sequential regression and simulation to model week six disease activity as a function of drug class, demographics, and disease-related features...
November 12, 2023: medRxiv
https://read.qxmd.com/read/37822534/the-promise-of-digital-healthcare-technologies
#18
REVIEW
Andy Wai Kan Yeung, Ali Torkamani, Atul J Butte, Benjamin S Glicksberg, Björn Schuller, Blanca Rodriguez, Daniel S W Ting, David Bates, Eva Schaden, Hanchuan Peng, Harald Willschke, Jeroen van der Laak, Josip Car, Kazem Rahimi, Leo Anthony Celi, Maciej Banach, Maria Kletecka-Pulker, Oliver Kimberger, Roland Eils, Sheikh Mohammed Shariful Islam, Stephen T Wong, Tien Yin Wong, Wei Gao, Søren Brunak, Atanas G Atanasov
Digital health technologies have been in use for many years in a wide spectrum of healthcare scenarios. This narrative review outlines the current use and the future strategies and significance of digital health technologies in modern healthcare applications. It covers the current state of the scientific field (delineating major strengths, limitations, and applications) and envisions the future impact of relevant emerging key technologies. Furthermore, we attempt to provide recommendations for innovative approaches that would accelerate and benefit the research, translation and utilization of digital health technologies...
2023: Frontiers in Public Health
https://read.qxmd.com/read/37789257/sequential-regression-and-simulation-a-method-for-estimating-causal-effects-from-heterogeneous-clinical-trials-without-a-common-control-group
#19
JOURNAL ARTICLE
Vivek A Rudrapatna, Vignesh G Ravindranath, Douglas V Arneson, Arman Mosenia, Atul J Butte, Shan Wang
BACKGROUND: The advent of clinical trial data sharing platforms has created opportunities for making new discoveries and answering important questions using already collected data. However, existing methods for meta-analyzing these data require the presence of shared control groups across studies, significantly limiting the number of questions that can be confidently addressed. We sought to develop a method for meta-analyzing potentially heterogeneous clinical trials even in the absence of a common control group...
October 3, 2023: BMC Medical Research Methodology
https://read.qxmd.com/read/37782497/second-line-pharmaceutical-treatments-for-patients-with-type-2-diabetes
#20
MULTICENTER STUDY
Rohit Vashisht, Ayan Patel, Lisa Dahm, Cora Han, Kathryn E Medders, Robert Mowers, Carrie L Byington, Suneil K Koliwad, Atul J Butte
IMPORTANCE: Assessing the relative effectiveness and safety of additional treatments when metformin monotherapy is insufficient remains a limiting factor in improving treatment choices in type 2 diabetes. OBJECTIVE: To determine whether data from electronic health records across the University of California Health system could be used to assess the comparative effectiveness and safety associated with 4 treatments in diabetes when added to metformin monotherapy. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, new user, multidimensional propensity score-matched retrospective cohort study with leave-one-medical-center-out (LOMCO) sensitivity analysis used principles of emulating target trial...
October 2, 2023: JAMA Network Open
keyword
keyword
26213
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.